Business Context and Reporting Period
Company: Acme United Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 1998
Business Overview: The Company manufactures and distributes consumer products (scissors, shears, rulers, first aid kits) in the U.S., Canada, England, and Germany. In March 1999, the Company sold its Medical Division, classifying it as discontinued operations. The Company reduced headcount from 433 to 312 during 1998.
Key Financial Metrics
| Metric | 1998 | 1997 |
|---|---|---|
| Net Sales (Continuing Ops) | $36.5 million | $32.8 million |
| Net Sales (Total incl. Discontinued) | $46.5 million | $46.3 million |
| Loss from Continuing Operations | $(2.4) million | $(2.8) million |
| Net Income (Loss) | $(1.7) million | $0.2 million |
| Income from Discontinued Ops | $0.7 million | $3.1 million |
| Gross Margin (Continuing Ops) | 21% | 22% |
| Working Capital | $3.6 million | $10.0 million |
| Current Ratio | 1.20 | 1.86 |
| Long-Term Debt | $6.4 million | $11.9 million |
| Cash Flow from Operations | $0.6 million | $(3.4) million |
Material Changes vs. Prior Period
- Revenue Growth: Continuing operations revenue increased 11% to $36.5 million, driven by a 10% increase in U.S. sales (Tagit! scissors, first aid kits) and a 39% increase in Canada (Rotex acquisition).
- Profitability: The Company reported a net loss of $1.7 million in 1998 compared to a net gain of $0.2 million in 1997. This was primarily due to the decline in income from the Medical Division (discontinued) and foreign currency losses of $194,000.
- Cost Structure: Gross margin declined slightly to 21% due to manufacturing inefficiencies and higher customer rebates. SG&A expenses decreased 2% due to headcount reductions.
- Liquidity: Working capital decreased significantly to $3.6 million (from $10.0 million) due to inventory reductions and increased accounts payable. However, operating cash flow turned positive ($0.6 million) compared to a $3.4 million outflow in 1997.
- Debt: Long-term debt decreased to $6.4 million following a refinancing and the use of proceeds from the Medical Division sale to repay approximately $6.0 million of bank debt in March 1999.
Guidance, Outlook, and Risks
- Strategic Shift: Management is focusing exclusively on the consumer market following the March 22, 1999, sale of the Medical Division for approximately $8.15 million (yielding a $2.0 million gain).
- Outlook: Management anticipates consistent profit growth in 1999, citing improved margins in Canada and Germany, the completion of the U.K. manufacturing exit, and lower costs from international suppliers.
- Financing: A new financing commitment allows borrowing up to $10.5 million, subject to covenants on tangible net worth and debt service coverage.
- Risks:
- Foreign Currency: Exposure to Canadian dollar, British pound, and German mark fluctuations.
- Year 2000 Compliance: Estimated costs of $225,000–$275,000; German systems are not yet fully compliant.
- Legal: Ongoing litigation regarding latex products (distributor only); management expects no material adverse impact.
Investor Verification Checklist
- Verify the realization of the $2.0 million gain on the sale of the Medical Division and the subsequent debt reduction.
- Monitor the ability to meet the new debt covenants (tangible net worth and debt service coverage) starting mid-1999.
- Assess the impact of foreign currency fluctuations on the Canadian and European operations, given the recent losses.
- Confirm the timeline and cost of Year 2000 compliance, specifically for the German subsidiary.
- Track the performance of new product lines (Tagit! scissors) and the integration of the Rotex inventory in Canada.